PRF and CGF Scaffolds With EDTA in Regeneration
RET-EDTA-CGF
Current Regenerative Approaches Applied to Immature Teeth With Necrotic Pulps
2 other identifiers
interventional
30
1 country
1
Brief Summary
This study evaluated the regenerative outcomes of immature permanent teeth with necrotic pulps treated using three scaffold types-blood clot, platelet-rich fibrin (PRF), and concentrated growth factor (CGF)-combined with either 5% or 17% EDTA as the final irrigant. Thirty teeth were randomly assigned to six treatment groups and followed clinically and radiographically for 12 months. Cone-beam computed tomography (CBCT) was used to assess root development parameters, including root length increase, apical diameter change, hard tissue formation, and periapical lesion volume. Clinical assessments included pain, swelling, sinus tract formation, percussion sensitivity, and pulp sensitivity testing. The study aimed to determine whether different scaffold materials and EDTA concentrations influence regenerative healing responses in immature necrotic teeth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 24, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedDecember 12, 2025
December 1, 2025
1 year
November 24, 2025
December 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Root Length Increase
Increase in root length measured using cone-beam computed tomography (CBCT).
Baseline to 12 months
Secondary Outcomes (5)
Apical Diameter Change (Apical Closure)
Baseline to 12 months
Periapical Lesion Volume Reduction
Baseline to 12 months
Hard Tissue Formation Volume
Baseline to 12 months
Pulp Sensitivity Response
12 months
Clinical Healing
Baseline, 6 months, and 12 months
Study Arms (6)
Blood Clot + 5% EDTA
EXPERIMENTALStandard regenerative endodontic treatment using final irrigation with 5% EDTA followed by induction of bleeding to form a blood clot scaffold.
Blood Clot + 17% EDTA
EXPERIMENTALRegenerative endodontic procedure using final irrigation with 17% EDTA and blood clot scaffold formation.
PRF + 5% EDTA
EXPERIMENTALRegenerative endodontic procedure using platelet-rich fibrin scaffold after final irrigation with 5% EDTA.
PRF + 17% EDTA
EXPERIMENTALRegenerative endodontic procedure using platelet-rich fibrin scaffold following final irrigation with 17% EDTA.
CGF + 5% EDTA
EXPERIMENTALRegenerative endodontic protocol using concentrated growth factor scaffold after final irrigation with 5% EDTA.
CGF + 17% EDTA
EXPERIMENTALRegenerative endodontic procedure using concentrated growth factor scaffold following final irrigation with 17% EDTA.
Interventions
Final irrigation with 17% EDTA followed by controlled induction of bleeding beyond the apex to produce a blood clot scaffold for regenerative endodontic treatment.
Application of platelet-rich fibrin (PRF) scaffold after final irrigation with 5% EDTA during regenerative endodontic therapy.
Use of platelet-rich fibrin (PRF) scaffold following final irrigation with 17% EDTA in regenerative endodontic treatment.
Placement of concentrated growth factor (CGF) scaffold after final irrigation with 5% EDTA as part of the regenerative endodontic protocol.
Placement of concentrated growth factor (CGF) scaffold following final irrigation with 17% EDTA during regenerative endodontic treatment.
Final irrigation with 5% EDTA followed by induction of apical bleeding to form an intracanal blood clot scaffold as part of the regenerative endodontic procedure.
Eligibility Criteria
You may qualify if:
- Immature permanent teeth with open apices
- Diagnosis of pulp necrosis
- Radiographic evidence of periapical pathology
- Teeth suitable for isolation and restoration
- Patients aged 9 to 25 years
- No systemic diseases that contraindicate dental treatment
- Willingness to attend follow-up visits
- Signed informed consent by patient or guardian
You may not qualify if:
- Teeth with root fractures
- Teeth with severe canal curvature (\>30°)
- Teeth with advanced root resorption
- Periodontal pocket depth \>3 mm
- Previous endodontic treatment or retreatment
- Pregnancy
- Use of antibiotics or analgesics within the last 7 days
- Nonrestorable crowns
- Uncooperative patients unable to attend follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaraş Sütçü İmam University, Faculty of Dentistry
Kahramanmaraş, 46010, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aliye Kamalak
Kahramanmaraş Sütçü İmam University, Faculty of Dentistry, Department of Endodontics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No blinding was possible because the type of scaffold (blood clot, PRF, or CGF) and the EDTA concentration (5% or 17%) were visibly identifiable during the clinical procedure. Operators could not be masked, and participants were aware of the treatment steps, making the study open label.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
November 24, 2025
First Posted
December 5, 2025
Study Start
October 1, 2023
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD), including CBCT images and clinical records, will not be shared due to patient confidentiality and ethical restrictions stated by the institutional review board.